title: Symptomatic interferon retinopathy successfully treated by hypertension management.
authors: C
authors: C
authors: Han
authors: J
authors: J
authors: O'Day
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D006973:Hypertension / Q000150:complications*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D012164:Retinal Diseases / Q000139:chemically induced*
chemical_list: D000959:Antihypertensive Agents; D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins
references: Am J Ophthalmol. 2001 Jun;131(6):782-7
references: 11384576
references: Liver. 2001 Jun;21(3):192-7
references: 11422782
references: J Hepatol. 2006 Jan;44(1):56-61
references: 16223542
references: Arch Ophthalmol. 1993 Mar;111(3):350-6
references: 8447745
references: Am J Gastroenterol. 1996 Feb;91(2):309-13
references: 8607498
references: J Immunol. 2004 Feb 1;172(3):1699-710
references: 14734752